Note: This story has been updated March 6, 2025, to correct a quote from Mindy Henderson, MDA vice president of…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
At its first virtual investor event, biotech company Centogene set a bold mission: to cure 100 rare diseases…
To help patient advocacy leaders and their partners better understand how global health statistics codes — known as ICD codes…
Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual…
How Will Pompe Disease Affect My Work Life?
If you have late-onset Pompe disease (LOPD) and are employed, or are considering employment, you’re likely going to need…
Your Daily Routine With Late Onset Pompe Disease
While the effects of late-onset Pompe disease on everyday life are far-reaching, there are steps you can take…
Shoshin for Adults Living With Pompe Disease
If you have a chronic disease such as late-onset Pompe disease, a Japanese concept called shoshin may help you…
Rare Disease Day at NIH, organized by the National Institutes of Health (NIH) and taking place on March 1,…
Scores of virtual events are afoot around the world to mark Rare Disease Day 2021 on Feb. 28. The…
While progress was made last year on newborn screening and other policy issues critical to rare disease patients, a “…